Nuclear Medicine Communications is a monthly rapid communications journal publishing research and clinical work in all areas of nuclear medicine for a global readership. In addition to original research papers, the journal features frankly written editorials, comprehensive reviews of current practice, and technical notes.
Nuclear Medicine and Biology publishes original research addressing all aspects of radiopharmaceutical science: synthesis, in vitro and ex vivo studies, in vivo biodistribution by dissection or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of targeted radiotracers. The importance of the target to a key disease should be the first consideration. If the synthesis of a new radiopharmaceutical is submitted without in vitro or in vivo data, then the uniqueness of the chemistry must be emphasized.These multidisciplinary studies should validate the mechanism of localization whether the probe is based on binding to a receptor, enzyme, tumor antigen, or another well-defined target. The studies should be aimed at evaluating how the chemical and radiopharmaceutical properties affect pharmacokinetics, pharmacodynamics, or therapeutic efficacy. Ideally, the study would address the sensitivity of the probe to changes in disease or treatment, although studies validating mechanism alone are acceptable. Radiopharmacy practice, addressing the issues of preparation, automation, quality control, dispensing, and regulations applicable to qualification and administration of radiopharmaceuticals to humans, is an important aspect of the developmental process, but only if the study has a significant impact on the field.Contributions on the subject of therapeutic radiopharmaceuticals also are appropriate provided that the specificity of labeled compound localization and therapeutic effect have been addressed. Supplemental information on the Aims and Scope can be found in the Jan issue of the Journal and at www.nucmedbio.com.
Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) is an official journal of the Korean Society of Nuclear Medicine, which quarterly publishes papers about nuclear medicine and related sciences such as radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal will also welcome original works relating to molecular imaging research such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Nucl Med Mol Imaging publishes the following types of papers: original articles, reviews, case reports, editorials, interesting images, and letters to the editor.
The Korean Society of Nuclear Medicine (KSNM)
KSNM is a scientific and professional organization founded in 1961 and a member of the Korean Academy of Medical Sciences of the Korean Medical Association which was established by The Medical Services Law. The aims of KSNM are the promotion of nuclear medicine and cooperation of each member. The business of KSNM includes holding academic meetings and symposia, the publication of journals and books, planning and research of promoting science and health, and training and qualification of nuclear medicine specialists.
Nuclear Physics A focuses on the domain of nuclear and hadronic physics and includes the following subsections: Nuclear Structure and Dynamics; Intermediate and High Energy Heavy Ion Physics; Hadronic Physics; Electromagnetic and Weak Interactions; Nuclear Astrophysics. The emphasis is on original research papers. A number of carefully selected and reviewed conference proceedings are published as an integral part of the journal.Editorial Aims and Scope click for pdf fileBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Nuclear Physics B focuses on the domain of high energy physics, quantum field theory, and statistical systems, and includes four main sections: high energy physics - phenomenology, high energy physics - theory, high energy physics - experiment, and quantum field theory and statistical systems. The emphasis is on original research papers (Frontiers Articles or Full Length Articles), but Review Articles are also welcome. More information on the different article types can be found in the Guide for Authors.Conference proceedings on the topics covered by Nuclear Physics B are published in the (separately available) journal Nuclear Physics B - Proceedings Supplements.We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: support.elsevier.com
Nuclear Physics B - Proceedings Supplements (NPB-PS) is the premier publication outlet for the proceedings of key conferences on high-energy physics and related areas. The series covers both large international conferences and topical meetings. The newest discoveries and the latest developments, reported at carefully selected meetings, are published covering experimental as well as theoretical particle physics, hadronic physics, cosmology, astrophysics and gravitation, field theory and statistical systems, and physical mathematics.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Nuclear Science and Engineering, the research journal of the American Nuclear Society, has been published since 1956. Now issued nine times a year, the journal is widely recognized as an outstanding source of information on research in all scientific areas related to the peaceful use of nuclear energy and radiation. Technical papers, notes, critical reviews, and computer code abstracts are presented.
Nuclear Technology is the leading international publication reporting on new information in all areas of the practical application of nuclear science. Topics include all aspects of reactor technology: operations, safety materials, instrumentation, fuel, and waste management. Also covered are medical uses, radiation detection, production of radiation, health physics, and computer applications.
Nuclear Technology & Radiation Protection is an international scientific journal covering the wide range of disciplines involved in nuclear science and technology as well as in the field of radiation protection. The journal is open for scientific papers, short papers, review articles, and technical papers dealing with nuclear power, research reactors, accelerators, nuclear materials, waste management, radiation measurements, and environmental problems. However, basic reactor physics and design, particle and radiation transport theory, and development of numerical methods and codes will also be important aspects of the editorial policy.Nuclear Technology & Radiation Protection is an open access journal included in ISI Web of Knowledge - Web of Science, Science citation index expanded - SCI, and Journal Citation Reports/Science Edition. The journal is available for full download at National Library of Serbia - doiSerbia, Directory of open access journals - DOAJ, and Portal of open access e-journals - Open J-Gate.
Nucleic Acids Research (NAR) publishes the results of leading edge research into physical, chemical, biochemical and biological aspects of nucleic acids and proteins involved in nucleic acid metabolism and/or interactions. It enables the rapid publication of papers under the following categories: Chemistry and synthetic biology; Computational biology; Gene regulation, chromatin and epigenetics; Genome integrity, repair and replication; Genomics; Molecular biology; Nucleic acid enzymes; RNA and Structural biology. A Survey and Summary section provides a format for brief reviews. The first issue of each year is devoted to biological databases, and an issue in July is devoted to papers describing web-based software resources of value to the biological community.NAR Methods Online provides a forum for the online publication of methods papers.The advent of online publication has greatly improved access to scientific content on a global scale. This has led to calls from the academic community for research to be made freely available online immediately upon publication, without the barrier of paid subscription to access.In response to these calls, and following consultation with journal contributors, Oxford University Press and the Editors of Nucleic Acids Research (NAR) launched an Open Access initiative for NAR in 2005. This means that it is no longer necessary to hold a subscription in order to read current NAR content online.There are substantial costs associated with publishing a high quality journal such as NAR, for example in the administration of the editorial process, production of the published version, and development of online functionality. Under a subscription-based model, these costs are primarily covered by charging libraries and individuals for access to the journal's content. Under NAR's Open Access model, we aim to cover the costs of publication primarily through a combination of author charges and institutional payments.